WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China's Labs Pull Ahead as Global Drugmakers I... (1/27/2026)

China's Early-Stage Drug Advantage Seen Persis... (1/27/2026)

China's Commercial Health Insurance Payouts fo... (1/23/2026)

China Emerges as Credible Challenger to US in ... (1/21/2026)

China Biopharma Innovation Takes Center Stage ... (1/17/2026)

China Biopharma Sees Record Financing and Lice... (1/13/2026)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

China's Biopharma Sector Sets New Record for I... (1/12/2026)

China's Innovative Drug Licensing Deals Reach ... (1/12/2026)

Asia Emerges as the New Epicenter of Global Bi... (1/8/2026)

Chinese Drug Makers Hit Record US$136B in Glob... (1/8/2026)

China Biopharma Approvals Surge in December as... (1/6/2026)

ADB Provides CNY 141M Loan to Support C... (1/28/2026) China Issues Trial Guidance on Pharmaceu... (1/28/2026) CDE Issues New Technical Guidance for Cl... (1/28/2026) NMPA Releases 101st Batch of Reference F... (1/28/2026) CTTQ's TQA3605 Shows Promising Phase 2 R... (1/27/2026) China Warns of Foreign Misuse of Researc... (1/27/2026) Lisata Regains Greater China Rights to P... (1/27/2026) Insilico Expands AI-Driven Cardiometabol... (1/27/2026) China Releases 2025 Edition Clinical Gui... (1/27/2026) China Issues Revised Implementing Regula... (1/27/2026) NMPA Adopts ICH M14 Guideline on Real-Wo... (1/27/2026) Boehringer Ingelheim Strikes €1.05B Dea... (1/27/2026) China's Vaccine Market Set for Slow but ... (1/27/2026) CDE Issues Technical Guidance on NMR Stu... (1/26/2026) NMPA Suspends Import, Sale and Use of Su... (1/26/2026) NMPA Suspends Import and Use of Chlorphe... (1/26/2026) Visen's Lonapegsomatropin Approved in Ch... (1/26/2026) Neowise Raises Over CNY 200M in Series B... (1/26/2026)

China's Vaccine Market Set for Slow but Steady Growth T... China Companion Animal Health Market to Reach US$ 3.7B ... China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri...

China Issues Trial Guidance on Pharmaceutical Research ... ADB Provides CNY 141M Loan to Support China's Communit... Boehringer Ingelheim Strikes €1.05B Deal With Simcere ... NMPA Adopts ICH M14 Guideline on Real-World Evidence fo... Insilico Expands AI-Driven Cardiometabolic Pipeline wit...

NMPA Releases 101st Batch of Reference Formulations for... CDE Issues New Technical Guidance for Clinical Trials o... China Issues Revised Implementing Regulations for the D... NMPA Suspends Import and Use of Chlorpheniramine Maleat... NMPA Suspends Import, Sale and Use of Sun Pharma's Riva...

China Releases 2025 Edition Clinical Guidance on the Us... NHSA Seeks Feedback on Draft Guidelines for Real-World... China Expands Cross-Province Use of Employee BMI Funds ... China Rolls Out Smart Medical Insurance Payments to Imp... China Convenes National Health Work Conference to Outli...

China Warns of Foreign Misuse of Research Ties to Acces... China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef...

Hybio Wins CNY 180M GLP-1 API Order as Novo Nordisk See... Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S...

CTTQ's TQA3605 Shows Promising Phase 2 Results in Chron... Huahui Wins Conditional Approval in China for First Hep... Visen's Lonapegsomatropin Approved in China for Pediatr... Insilicon Secures FDA IND Clearance for Oral NLRP3 Inhi... Mabwell Advances CDH17 ADC Program with First U.S. Pati...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...